I&#x27;ve been maintaining for a while that Theranos is a very cynical investment vehicle, and has little to do with medicine. The backgrounds of those connected, of her family, of the trajectory and direction of the company (everything has been <i>very</i> PR and financial press oriented) suggests that their key mission is to grow the value of the company, rather than do anything novel.<p>The sad thing is, this seems to be an increasingly common strategy in a certain segment of the business world, and it brings value to nobody ultimately - it just separates optimistic investors who just see a wunderkind and incredible new technology from their money.